Breyna is a pharmaceutical product.
What is Breyna used for?
Breyna is a smart inhaler indicated for the treatment of asthma in patients aged 12 years and older [1]. It is designed to be used as a reliever medication.
How does Breyna work?
Breyna is a combination inhaler containing albuterol and budesonide [1]. Albuterol is a short-acting beta2-adrenergic agonist (SABA) that relaxes the muscles in the airways, helping to open them up. Budesonide is an inhaled corticosteroid (ICS) that reduces inflammation in the airways. By combining these two medications, Breyna aims to provide both immediate relief from asthma symptoms and reduce underlying airway inflammation.
When was Breyna approved?
Breyna received FDA approval on July 28, 2021 [1].
Who makes Breyna?
Breyna is manufactured by Kindeva Drug Delivery L.P. [1].
What is the patent status of Breyna?
Information regarding the specific patents covering Breyna and their expiry dates can be found on DrugPatentWatch.com [2].
How does Breyna compare to other asthma treatments?
Breyna's dual action of a SABA and an ICS in a single inhaler offers a different approach to asthma management compared to treatments that only use a SABA for symptom relief or require separate inhalers for bronchodilation and inflammation control. This combination therapy aims to address both the immediate symptoms and the underlying inflammatory processes contributing to asthma.
What are the potential risks or side effects of Breyna?
As with any medication, Breyna may have potential risks and side effects. Patients and healthcare providers should consult the full prescribing information for a comprehensive list of adverse events. Common side effects associated with SABAs can include tremor, nervousness, and increased heart rate, while ICS can be associated with oral thrush and hoarseness.
Can Breyna be used for COPD?
Breyna is specifically indicated for the treatment of asthma in patients aged 12 years and older [1]. Its use for other respiratory conditions like COPD would require separate evaluation and approval.
What is a smart inhaler?
A smart inhaler, like Breyna, typically incorporates technology that can help track medication usage. This can provide data to patients and healthcare providers to better understand adherence and symptom patterns, potentially leading to more optimized treatment [1].
Sources:
[1] https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-breyna-albuterol-and-budesonide-inhalation-aerosol-asthma
[2] https://drugpatentwatch.com/